Skip to main content

Table 1 Baseline sociodemographic and clinical characteristics, adherence, and satisfaction among participants with clinical levels of baseline depressive or anxiety symptoms

From: Demographic and clinical characteristics associated with anxiety and depressive symptom outcomes in users of a digital mental health intervention incorporating a relational agent

 

Participants with PHQ-8 baseline score ≥ 10 N = 111 n (%)

Participants with GAD-7 baseline score ≥ 10 N = 107 n (%)

Sociodemographic Characteristic

 Age in years (mean, sd)

38 (13.57)

37 (12.28)

Race/ethnicity

 Non-Hispanic Black

37 (33%)

32 (30%)

 Non-Hispanic White

55 (50%)

56 (52%)

 Other

19 (17%)

19 (18%)

Sex at Birth

 Female

83 (75%)

81 (76%)

 Male

28 (25%)

26 (24%)

Sexual Orientation

 Sexual Minority

19 (17%)

19 (18%)

 Heterosexual

92 (83%)

88 (82%)

Education

 Graduate or Postgraduate Degree

32 (29%)

24 (23%)

 College Degree

43 (39%)

43 (41%)

 Some College or technical school

21 (19%)

22 (21%)

 High School (Grades 9—12)

14 (13%)

16 (15%)

Employment

 Full Time Employed

53 (49%)

57 (54%)

 Part Time Employed

11 (10%)

9 (9%)

 Not Employed

29 (27%)

22 (21%)

 Other

15 (14%)

17 (16%)

Marital Status

 Divorced/Separated/Widowed

10 (9%)

10 (10%)

 Married/Partnered/cohabiting

50 (47%)

48 (46%)

 Single

47 (44%)

47 (45%)

Health Insurance

 Government Based Insurance

40 (37%)

37 (36%)

 Private Insurance

46 (43%)

45 (43%)

 No Insurance/ Prefer not to answer

21 (20%)

22 (21%)

Clinical Characteristics

Baseline Depressive symptom severity

 Minimal

0 (0%)

7 (7%)

 Mild

0 (0%)

21 (20%)

 Moderate

55 (50%)

25 (23%)

 Moderate-severe

30 (27%)

29 (27%)

 Severe

26 (23%)

25 (23%)

Baseline Anxiety symptom severity

 Minimal

3 (3%)

0 (0%)

 Mild

29 (26%)

0 (0%)

 Moderate

37 (33%)

60 (56%)

 Severe

42 (38%)

47 (44%)

Concurrent Mental Health Treatmenta

 Any (Concurrent treatment)

54 (49%)

57 (53%)

 None (Woebot only)

57 (51%)

50 (47%)

Adherence Metrics

App Utilization

 Use of W-MA-02 in at least 4 of 8 weeks

74 (67%)

69 (64%)

 Per protocol data set

71 (64%)

63 (59%)

  1. “Per protocol” was defined as using W-MA-02 in at least 4 of 8 study weeks and completing end of study PHQ-8 and GAD-7 assessments
  2. GAD-7 Generalized Anxiety Disorder-7 item scale, PHQ-8 Patient Health Questionnaire-8 item scale
  3. aConcurrent mental health treatment = any psychotherapy or psychotropic medication use at any time during the study